Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

The Evolving Drug Development Landscape: From Blockbusters to Niche Busters in the Orphan Drug Space

12 references·1 citing·38 second hop

FromToDepth

this work references cited by second hop

References

2007Assessing the economic challenges posed by orphan drugs279 cited
2011Pricing and reimbursement of orphan drugs: the need for more transparency261 cited
2012Orphan drug development: an economically viable strategy for biopharma R&D161 cited
2010Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years148 cited
2002Two decades of orphan product development138 cited
2008Incentives for orphan drug research and development in the United States138 cited
2011Rare Diseases and Orphan Products135 cited
2012What Is Wrong with Orphan Drug Policies?110 cited
2006Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products88 cited
2009Translation of rare disease research into orphan drug development: disease matters75 cited
1990Orphan Drug Act63 cited
2011Accelerating access to treatments for rare diseases62 cited

Cited by

2017Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare Diseases47 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work